# Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)

> **NCT00133237** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 607 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** Sirolimus-eluting stent
- **DEVICE:** Paclitaxel-eluting stent

## Key facts

- **NCT ID:** NCT00133237
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 607 (ACTUAL)
- **Last updated:** 2010-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133237, "Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00133237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*